Evidence map›Paper›PMID 25587317›Full record

ArticleIranian journal of pharmaceutical research : IJPR2014

The Effects of Extending of Co-planarity in a Series of Structurally Relative Polypyridyl Palladium(II) Complexes on DNA-binding and Cytotoxicity Properties.

Somaye Shahraki, Hassan Mansouri-Torshizi, Ziba Sori Nezami, Arezou Ghahghaei, Fatemeh Yaghoubi, Adeleh Divsalar, Ali-Akbar Saboury, Farshad H Shirazi

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Somaye ShahrakiDepartment of Chemistry, University of Sistan & Baluchestan, Zahedan, Iran.
Hassan Mansouri-TorshiziDepartment of Chemistry, University of Sistan & Baluchestan, Zahedan, Iran.
Ziba Sori NezamiDepartment of Chemistry, University of Sistan & Baluchestan, Zahedan, Iran.
Arezou GhahghaeiDepartment of Biology, University of Sistan & Baluchestan, Zahedan, Iran.
Fatemeh YaghoubiDepartment of Chemistry, University of Sistan & Baluchestan, Zahedan, Iran.
Adeleh DivsalarDepartment of Biological Sciences, Tarbiat Moallem University, Tehran, Iran.
Ali-Akbar SabouryInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Farshad H ShiraziPharmaceutical Sciences Research Center, Shahid Behesthi University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In depth interaction studies between calf thymus deoxyribonucleic acid (CT-DNA) and a series of four structurally relative palladium(II) complexes [Pd(en)(HB)](NO3)2 (a-d), where en is ethylenediamine and heterocyclic base (HB) is 2,2'-bipyridine (bpy, a); 1,10-phenanthroline (phen, b); dipyridoquinoxaline (dpq, c) and dipyridophenazine (dppz, d) (Figure 1), were performed. These studies have been investigated by utilizing the electronic absorption spectroscopy, fluorescence spectra and ethidium bromide (EBr) displacement and gel filtration techniques. a-d complexes cooperatively bind and denature the DNA at low concentrations. Their concentration at midpoint of transition, L1/2, follows the order a >> b > c > d. Also the g, the number of binding sites per 1000 nucleotides, follows the order a >> b ~ c > d. EBr and Scatchard experiments for a-d complexes suggest efficient intercalative binding affinity to CT-DNA giving the order: d > c > b > a. Several binding and thermodynamic parameters are also described. The biological activity of these cationic and water soluble palladium complexes were tested against chronic myelogenous leukemia cell line, K562. b, c and d complexes show cytotoxic concentration (Cc50) values much lower than cisplatin.

Indexed as

CytotoxicityDNA bindingPd(II) complexes

Identifiers

PMID25587317
PMCPMC4232794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.